Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,735
Out of 4,789 analysts
18
Total ratings
n/a
Success rate
-37.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.36 | +1,223.53% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $16.61 | +2.35% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $2.86 | +1,088.81% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $116.63 | -18.55% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $7.95 | +415.72% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $0.72 | +177.78% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.28 | +11,483.01% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $2.04 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.75 | +456.52% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.36
Upside: +1,223.53%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $16.61
Upside: +2.35%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $2.86
Upside: +1,088.81%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $116.63
Upside: -18.55%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $7.95
Upside: +415.72%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $0.72
Upside: +177.78%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.28
Upside: +11,483.01%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $2.04
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.75
Upside: +456.52%